Predictors of survival and time to progression following operative management of intramedullary spinal cord astrocytomas

ConclusionTumor grade and chemotherapy were associated with poorer survival and progression-free survival. Chemotherapy regimens were highly heterogeneous, and randomized trials are needed to determine if any optimal regimens exist. Additionally, GTR was associated with improved survival, and patients should be counseled about the benefits and risks of resection extent.
Source: Journal of Neuro-Oncology - Category: Cancer & Oncology Source Type: research